Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia

Claire Roberts1, Panida Winter, Claire S Shilliam

  • 1Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, CM19 5AW, Harlow, Essex, UK. Claire_2_Roberts@gsk.com